Showcased in Düsseldorf, IMA is positioning ASSEMBLA to address the needs of an "increasingly complex industry, characterised by evolving product designs, variable volumes and stringent regulatory requirements."
The company said the new approach to assembly will bring flexibility, scalability and validation reliability to customers.
"With ASSEMBLA, we are introducing a universal platform that combines modularity, performance and validation reliability," said IMA MED-TECH.
One frame, infinite configurations, any production volume.
Modular architecture and continuous scalability
ASSEMBLA is based on a single extendable frame, expandable from two to six meters and configurable through interconnected modules in horizontal, vertical or hybrid layouts.
IMA MED-TECH said this architecture allows the platform to be tailored to specific process requirements, optimising footprint and performance.
The solution covers a productivity range from 20 to more than 500 parts per minute, enabling a continuous growth path for the following:
- semi-automatic units for laboratory and clinical trials
- automatic cells for small and mid-scale production
- and industrial lines up to high and ultra-high-performance systems.
ASSEMBLA will be able to support multi-device and multi-generation production across several application fields, including injectables, inhalers, diagnostics, wearable technologies and ophthalmic systems.
Integrated technology for quality and compliance
Leveraging more than 60 years of IMA's industrial expertise, this new platform integrates advanced technologies to ensure precision, traceability and product integrity.
ASSEMBLA is compatible with major control systems (PLCs) and can be integrated with various transport technologies, including magnetic systems, thereby simplifying validation processes.
The platform also features IoT connectivity, advanced monitoring and pre-batch verification tools.
ASSEMBLA has been designed as a modular ecosystem, enabling manufacturers to adapt quickly to evolving products and production requirements.
IMA MED-TECH solution portfolio
During Interpack 2026, IMA MED-TECH presented its portfolio of turnkey solutions for medical device assembly, including the following:
- X-PEN LAB, for development and pilot production up to 20 ppm
- X-PEN, for industrial production up to 160 ppm
- ASSEMBLA, multi-device engineer-to-order platform
- and solutions for the assembly of inhalers, diagnostic devices, wearable technologies, surgical instruments, contact lenses and intraocular lenses (IOLs).
IMA added that the new ASSEMBLA now serves as a strategic solution within the firm's portfolio, aiding customers in the industrialisation and scalability of medical devices.